Cargando…

Tissue engineered aortic valve

Several prostheses are available to replace degenerative diseased aortic valves with unique advantages and disadvantages. Bioprotheses show excellent hemodynamic behavior and low risk of thromboembolic complications, but are limited by tissue deterioration. Mechanical heart valves have extended dura...

Descripción completa

Detalles Bibliográficos
Autor principal: Dohmen, P M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDIMES Edizioni Internazionali Srl 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484929/
https://www.ncbi.nlm.nih.gov/pubmed/23440902
_version_ 1782248208875913216
author Dohmen, P M
author_facet Dohmen, P M
author_sort Dohmen, P M
collection PubMed
description Several prostheses are available to replace degenerative diseased aortic valves with unique advantages and disadvantages. Bioprotheses show excellent hemodynamic behavior and low risk of thromboembolic complications, but are limited by tissue deterioration. Mechanical heart valves have extended durability, but permanent anticoagulation is mandatory. Tissue engineering created a new generation heart valve, which overcome limitations of biological and mechanical heart valves due to remodelling, regeneration and growth potential. Several publications are available in using tissue engineered heart valves in right ventricular outflow tract reconstruction. Limited experiences are available on these heart valves implanted into the systemic circulation. This overview shows the current state on the development of tissue engineered aortic heart valves.
format Online
Article
Text
id pubmed-3484929
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher EDIMES Edizioni Internazionali Srl
record_format MEDLINE/PubMed
spelling pubmed-34849292013-02-25 Tissue engineered aortic valve Dohmen, P M HSR Proc Intensive Care Cardiovasc Anesth Brief-Report Several prostheses are available to replace degenerative diseased aortic valves with unique advantages and disadvantages. Bioprotheses show excellent hemodynamic behavior and low risk of thromboembolic complications, but are limited by tissue deterioration. Mechanical heart valves have extended durability, but permanent anticoagulation is mandatory. Tissue engineering created a new generation heart valve, which overcome limitations of biological and mechanical heart valves due to remodelling, regeneration and growth potential. Several publications are available in using tissue engineered heart valves in right ventricular outflow tract reconstruction. Limited experiences are available on these heart valves implanted into the systemic circulation. This overview shows the current state on the development of tissue engineered aortic heart valves. EDIMES Edizioni Internazionali Srl 2012 /pmc/articles/PMC3484929/ /pubmed/23440902 Text en Copyright © 2012, HSR Proceedings in Intensive Care and Cardiovascular Anesthesia http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License 3.0, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode.
spellingShingle Brief-Report
Dohmen, P M
Tissue engineered aortic valve
title Tissue engineered aortic valve
title_full Tissue engineered aortic valve
title_fullStr Tissue engineered aortic valve
title_full_unstemmed Tissue engineered aortic valve
title_short Tissue engineered aortic valve
title_sort tissue engineered aortic valve
topic Brief-Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484929/
https://www.ncbi.nlm.nih.gov/pubmed/23440902
work_keys_str_mv AT dohmenpm tissueengineeredaorticvalve